Tag: intrasaccular device
Galaxy completes enrolment in pivotal trial evaluating Seal intrasaccular device
Galaxy Therapeutics has announced it has successfully completed enrolment in SEAL IT, the company’s US investigational device exemption (IDE) pivotal trial evaluating the Seal...
Arissa completes enrolment in Syntra pilot study for treatment of wide-necked...
Arissa Medical has announced that it has completed enrolment in a pilot study evaluating the safety and efficacy of the company’s Syntra device for...
One-year data show high rates of complete occlusion and safety following...
This advertorial, intended only for audiences outside the USA, is sponsored by Medtronic.
Following the European launch of Artisse™ last year, 12-month data on the...
Fifteen years of the WEB embolisation system: a transformative journey in...
This supplement is sponsored by Terumo Neuro.
In this eight-page supplement, several pioneers in the endovascular treatment of brain aneurysms discuss the Woven EndoBridge (WEB;...
CONTRA study provides encouragement on use of Contour device in ruptured...
New data from the CONTRA study—presented for the first time by Jens Fiehler (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) at the 2025 European Society...
Galaxy Therapeutics completes enrolment of primary cohort in pivotal SEAL IT...
Galaxy Therapeutics has today announced completed enrolment of the primary cohort of patients in its SEAL IT investigational device exemption (IDE) trial.
The trial's primary...
Meta-analysis of nearly 500 patients synthesises current data on novel intrasaccular...
A systematic review and meta-analysis published recently in the Journal of NeuroInterventional Surgery has synthesised the existing data on intracranial aneurysm treatments utilising the...
Endostream announces European MDR certification of Nautilus intrasaccular system
Endostream Medical has announced that it has officially received European Union (EU) Medical Device Regulation (MDR) certification for its Nautilus intrasaccular system—a novel device...
Arissa Medical enrols third cohort of patients in first-in-human Syntra pilot...
Arissa Medical has announced the third enrolment of patients into its Syntra study—an early feasibility pilot study evaluating the safety and efficacy of the...
Microvention announces publication of one-year results from CLEVER study
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the recent publication in the Journal of NeuroInterventional Surgery (JNIS) of one-year results from...
Medtronic unveils next-generation Artisse intrasaccular device alongside new data at LINNC...
Medtronic has today announced the European launch of Artisse—a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the...
Conformability, softness, simplicity and simulation enable Artisse to ‘personalise’ treatments in...
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
In light of the official European launch of the Artisse aneurysm embolisation...
Arissa Medical enrols first patients in first-in-human Syntra study
Arissa Medical has announced the enrolment of the first patients in its Syntra study—a first-in-human (FIH), early feasibility study evaluating the safety and efficacy...
Arissa Medical announces positive feasibility study results with Syntra intrasaccular scaffold
Arissa Medical has announced the successful evaluation of the Syntra intrasaccular scaffold system within simulated use conditions under fluoroscopy using clinically relevant, in-vitro intracranial...
“The third way” in intrasaccular aneurysm treatment demonstrates positive one-year outcomes
A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one...
Nautilus represents “next evolution” of intrasaccular systems in aneurysm care
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Microvention announces five-year WEB-IT data alongside two new device sizes
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
